Healios K.K. (OTCMKTS:HLOSF) Short Interest Down 92.4% in November

Healios K.K. (OTCMKTS:HLOSF) was the recipient of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 4,800 shares, a decrease of 92.4% from the October 31st total of 62,900 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Healios K.K. Price Performance

Healios K.K. stock remained flat at 1.20 during trading hours on Thursday. Healios K.K. has a 12-month low of 0.93 and a 12-month high of 1.73. The stock has a fifty day moving average of 1.54 and a 200 day moving average of 1.34.

About Healios K.K.

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.